{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:36:07Z","timestamp":1790422567436,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.cjca.2014.04.016","type":"journal-article","created":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T14:04:11Z","timestamp":1398434651000},"page":"879-887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Oral Anticoagulation for Pulmonary Arterial Hypertension: Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"30","author":[{"given":"Daniel","family":"Caldeira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Loureiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto J.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim J.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2014.04.016_bib1","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.04.016_bib2","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.04.016_bib3","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1183\/09031936.06.00015206","article-title":"Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review","volume":"28","author":"Johnson","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cjca.2014.04.016_bib4","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3899\/jrheum.100632","article-title":"Effect of warfarin on survival in scleroderma-associated pulmonary arterial hypertension (SSc-PAH) and idiopathic PAH. Belief elicitation for Bayesian priors","volume":"38","author":"Johnson","year":"2011","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.cjca.2014.04.016_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/CIRCULATIONAHA.113.004526","article-title":"Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)","volume":"129","author":"Olsson","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.04.016_bib6","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2014.04.016_bib7","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/sim.1188","article-title":"Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes","volume":"21","author":"Deeks","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.cjca.2014.04.016_bib8","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1128\/AAC.48.8.2787-2792.2004","article-title":"Hazard ratio in clinical trials","volume":"48","author":"Spruance","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cjca.2014.04.016_bib9","unstructured":"Higgins JP, Altman DG, Sterne JA, eds. Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org. Accessed June 1, 2013."},{"key":"10.1016\/j.cjca.2014.04.016_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-7622-5-23","article-title":"Development of a Quality Assessment Tool for Systematic Reviews of Observational Studies (QATSO) of HIV prevalence in men having sex with men and associated risk behaviours","volume":"5","author":"Wong","year":"2008","journal-title":"Emerg Themes Epidemiol"},{"key":"10.1016\/j.cjca.2014.04.016_bib11","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/EDE.0b013e3181577654","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"18","author":"von Elm","year":"2007","journal-title":"Epidemiology"},{"key":"10.1016\/j.cjca.2014.04.016_bib12","doi-asserted-by":"crossref","first-page":"d4488","DOI":"10.1136\/bmj.d4488","article-title":"Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis","volume":"343","author":"Buitrago-Lopez","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2014.04.016_bib13","doi-asserted-by":"crossref","first-page":"e4260","DOI":"10.1136\/bmj.e4260","article-title":"Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis","volume":"345","author":"Caldeira","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2014.04.016_bib14","unstructured":"Wells G, Shea B, O'Connell D, et\u00a0al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm. Accessed May 23,\u00a02013."},{"key":"10.1016\/j.cjca.2014.04.016_bib15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cjca.2014.04.016_bib16","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1183\/09031936.00042107","article-title":"A\u00a0USA-based registry for pulmonary arterial hypertension: 1982-2006","volume":"30","author":"Thenappan","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cjca.2014.04.016_bib17","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry","volume":"142","author":"Benza","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2014.04.016_bib18","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1161\/CIRCULATIONAHA.104.503540","article-title":"Pulmonary arterial hypertension","volume":"114","author":"McLaughlin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.04.016_bib19","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.cjca.2014.04.016_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1016\/j.cjca.2014.04.016_bib21","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.cjca.2014.04.016_bib22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2014.04.016_bib23","series-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","first-page":"313","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","author":"Deeks","year":"2001"},{"key":"10.1016\/j.cjca.2014.04.016_bib24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2014.04.016_bib25","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jama.295.6.676","article-title":"Comparison of two methods to detect publication bias in meta-analysis","volume":"295","author":"Peters","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2014.04.016_bib26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.0954-6820.1966.tb05449.x","article-title":"Primary pulmonary hypertension with emphasis on its etiology and treatment","volume":"179","author":"Storstein","year":"1966","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.cjca.2014.04.016_bib27","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.CIR.70.4.580","article-title":"Primary pulmonary hypertension: natural history and the importance of thrombosis","volume":"70","author":"Fuster","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.04.016_bib28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.04.016_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1253\/jcj.57.63","article-title":"Effects of a combination therapy of anticoagulant and vasodilator on the long-term prognosis of primary pulmonary hypertension","volume":"57","author":"Ogata","year":"1993","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.cjca.2014.04.016_bib30","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1378\/chest.112.3.714","article-title":"The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension","volume":"112","author":"Frank","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2014.04.016_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.amjcard.2004.09.006","article-title":"New predictors of outcome in idiopathic pulmonary arterial hypertension","volume":"95","author":"Kawut","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2014.04.016_bib32","first-page":"A16034","article-title":"Effect of warfarin on long term pulmonary arterial hypertension (PAH) mortality: change of facts?","volume":"124","author":"Saeed","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.04.016_bib33","doi-asserted-by":"crossref","first-page":"R213","DOI":"10.1186\/ar4051","article-title":"Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study","volume":"14","author":"Ngian","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cjca.2014.04.016_bib34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0300-8932(10)70066-X","article-title":"Evidence-based management of right heart failure: a systematic review of an empiric field","volume":"63","author":"Skhiri","year":"2010","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.cjca.2014.04.016_bib35","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1002\/j.1875-9114.2012.01105.x","article-title":"Key articles and guidelines in the management of pulmonary arterial hypertension: 2011 update","volume":"32","author":"Johnson","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cjca.2014.04.016_bib36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0012-3692(15)51873-4","article-title":"Thrombotic arteriopathy and anticoagulation in pulmonary hypertension","volume":"130","author":"Johnson","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2014.04.016_bib37","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2014.04.016_bib38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1183\/09031936.00057010","article-title":"Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension","volume":"36","author":"Humbert","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cjca.2014.04.016_bib39","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1136\/annrheumdis-2012-202489","article-title":"Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era","volume":"72","author":"Launay","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cjca.2014.04.016_bib40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/eurheartj\/ehp022","article-title":"A\u00a0meta-analysis of randomized controlled trials in pulmonary arterial hypertension","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.04.016_bib41","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(60)91854-7","article-title":"Anticoagulant treatment of obliterative pulmonary hypertension","volume":"2","author":"Wilcken","year":"1960","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2014.04.016_bib42","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(04)17670-8","article-title":"External validity of randomised controlled trials: \u201cto whom do the results of this trial apply?\u201d","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2014.04.016_bib43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1017\/S0266462309990122","article-title":"Inadequate reporting of trials compromises the applicability of systematic reviews","volume":"25","author":"Gartlehner","year":"2009","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.cjca.2014.04.016_bib44","doi-asserted-by":"crossref","first-page":"e1001026","DOI":"10.1371\/journal.pmed.1001026","article-title":"Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview","volume":"8","author":"Golder","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.cjca.2014.04.016_bib45","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.7326\/0003-4819-142-12_Part_2-200506211-00009","article-title":"Challenges in systematic reviews that assess treatment harms","volume":"142","author":"Chou","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2014.04.016_bib46","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/01.CIR.80.5.1198","article-title":"Histopathology of primary pulmonary hypertension: a qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry","volume":"80","author":"Pietra","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.04.016_bib47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0025-6196(12)65277-X","article-title":"Primary pulmonary hypertension: a histopathologic study of 80 cases","volume":"60","author":"Bjornsson","year":"1985","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cjca.2014.04.016_bib48","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1378\/chest.110.3.710","article-title":"Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension","volume":"110","author":"Welsh","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2014.04.016_bib49","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1345\/aph.1C398","article-title":"Bosentan and warfarin interaction","volume":"37","author":"Murphey","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cjca.2014.04.016_bib50","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.4081\/hr.2011.e16","article-title":"Bosentan and oral anticoagulants in HIV patients: what we can learn of cases reported so far","volume":"3","author":"Morales-Molina","year":"2011","journal-title":"Hematol Rep"},{"key":"10.1016\/j.cjca.2014.04.016_bib51","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1586\/14779072.3.6.985","article-title":"Sitaxsentan: a novel endothelin-A receptor antagonist for pulmonary arterial hypertension","volume":"3","author":"Widlitz","year":"2005","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.cjca.2014.04.016_bib52","doi-asserted-by":"crossref","first-page":"760S","DOI":"10.1378\/chest.126.4_MeetingAbstracts.760S-b","article-title":"Thrombocytopenia associated with chronic intravenous epoprostenol therapy","volume":"126","author":"Hargett","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2014.04.016_bib53","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(84)91855-5","article-title":"Altered platelet function in patients on continuous infusions of epoprostenol","volume":"1","author":"Yardumian","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2014.04.016_bib54","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1183\/09031936.00039212","article-title":"Major bleeding with vitamin K antagonist anticoagulants in pulmonary hypertension","volume":"41","author":"Henkens","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cjca.2014.04.016_bib55","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3899\/jrheum.110765","article-title":"Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease","volume":"39","author":"Johnson","year":"2012","journal-title":"J\u00a0Rheumatol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X14002827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X14002827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T16:51:44Z","timestamp":1538671904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X14002827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0828282X14002827"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2014.04.016","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Anticoagulation for Pulmonary Arterial Hypertension: Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2014.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}